Presentation is loading. Please wait.

Presentation is loading. Please wait.

Case 1: Introduction. Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?

Similar presentations


Presentation on theme: "Case 1: Introduction. Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?"— Presentation transcript:

1 Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?

2 Case 1: Introduction

3 Case 1: Imaging and Laboratory Results

4 Case 1: Imaging and Laboratory Results

5 Organ Function and Age

6 Decline in Lung Function With Age and Smoking

7 Surgical Management and Outcomes in Older Patients with Early-Stage NSCLC

8 Improved Outcomes With Higher Surgery Rates for Older Patients With NSCLC

9 Case 1: Surgical Evaluation

10 Case 1: Surgical Evaluation

11 CALGB 9633

12 JBR.10 Trial: Overall Survival

13 Survival by Age: Meta-Analysis

14

15

16 Overall Survival by Age Group in the Postadoption Cohort 2004-2006*

17 Postoperative Adjuvant Chemotherapy in Older Patients

18 Adjuvant Therapy: Cisplatin vs Carboplatin

19 Case 1: Treatment

20 Case 2: Patient Introduction

21 Case 2: Patient Introduction

22 TREAT Study Design

23 TREAT Study Results

24 Interim Analysis of ECOG 1505: Chemotherapy Administered

25 Interim Analysis of ECOG 1505: Toxicity

26 Case 2: Treatment

27 Thank you for participating in this activity.


Download ppt "Case 1: Introduction. Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?"

Similar presentations


Ads by Google